Literature DB >> 18186569

Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients.

K A Attia1, K C Ackoundou-N'guessan, A T N'dri-Yoman, A K Mahassadi, E Messou, Y F Bathaix, Y H Kissi.   

Abstract

AIM: To compare the performance of the Child-Pugh-Turcott (CPT) score to that of the model for end-stage liver disease (MELD) score in predicting survival of a retrospective cohort of 172 Black African patients with cirrhosis on a short and mid-term basis.
METHODS: Univariate and multivariate (Cox model) analyses were used to identify factors related to mortality. Relationship between the two scores was appreciated by calculating the correlation coefficient. The Kaplan Meier method and the log rank test were used to elaborate and compare survival respectively. The Areas Under the Curves were used to compare the performance between scores at 3, 6 and 12 mo.
RESULTS: The study population comprised 172 patients, of which 68.9% were male. The mean age of the patient was 47.5 +/- 13 years. Hepatitis B virus infection was the cause of cirrhosis in 70% of the cases. The overall mortality was 31.4% over 11 years of follow up. Independent factors significantly associated with mortality were: CPT score (HR = 3.3, 95% CI [1.7-6.2]) (P < 0.001) (stage C vs stage A-B); Serum creatine (HR = 2.5, 95% CI [1.4-4.3]) (P = 0.001) (Serum creatine > 1.5 mg/dL versus serum creatine < 1.5 mg/dL); MELD score (HR = 2.9, 95% CI [1.63-5.21]) (P < 0.001) (MELD > 21 vs MELD < 21). The area under the curves (AUC) that predict survival was 0.72 and 0.75 at 3 mo (P = 0.68), 0.64 and 0.62 at 6 mo (P = 0.67), 0.69 and 0.64 at 12 mo (P = 0.38) respectively for the CPT score and the MELD score.
CONCLUSION: The CPT score displays the same prognostic significance as does the MELD score in black African patients with cirrhosis. Moreover, its handling appears less cumbersome in clinical practice as compared to the latter.

Entities:  

Mesh:

Year:  2008        PMID: 18186569      PMCID: PMC2675128          DOI: 10.3748/wjg.14.286

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  41 in total

Review 1.  Epidemiology of hepatitis B in Europe and worldwide.

Authors:  Miriam J Alter
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

Review 2.  Measurement of intracellular Ca2+ concentration.

Authors:  Nicolas Demaurex; Serge Arnaudeau; Michal Opas
Journal:  Methods Cell Biol       Date:  2002       Impact factor: 1.441

3.  Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial.

Authors:  R P Beasley; L Y Hwang; C C Lin; C E Stevens; K Y Wang; T S Sun; F J Hsieh; W Szmuness
Journal:  Lancet       Date:  1981-08-22       Impact factor: 79.321

Review 4.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

5.  [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].

Authors:  T Fejfar; V Safka; P Hůlek; T Vanásek; A Krajina; V Jirkovský
Journal:  Vnitr Lek       Date:  2006-09

6.  Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state.

Authors:  B J McMahon; W L Alward; D B Hall; W L Heyward; T R Bender; D P Francis; J E Maynard
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

Review 7.  Hepatorenal syndrome.

Authors:  Pere Ginès; Mónica Guevara; Vicente Arroyo; Juan Rodés
Journal:  Lancet       Date:  2003-11-29       Impact factor: 79.321

Review 8.  Pathophysiology, diagnosis and treatment of ascites in cirrhosis.

Authors:  Vicente Arroyo
Journal:  Ann Hepatol       Date:  2002 Apr-Jun       Impact factor: 2.400

9.  Predictive indices of morbidity and mortality after liver resection.

Authors:  Rebecca A Schroeder; Carlos E Marroquin; Barbara Phillips Bute; Shukri Khuri; William G Henderson; Paul C Kuo
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

10.  Household clustering and intra-household transmission patterns of hepatitis B virus infection in South Africa.

Authors:  S S Abdool Karim; R Thejpal; H M Coovadia
Journal:  Int J Epidemiol       Date:  1991-06       Impact factor: 7.196

View more
  11 in total

Review 1.  Prioritization for liver transplantation.

Authors:  Evangelos Cholongitas; Giacomo Germani; Andrew K Burroughs
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

2.  Pretransplant ascites and encephalopathy and their influence on survival and liver graft rejection in alcoholic cirrhosis disease.

Authors:  Isabel Legaz; Jose M Bolarin; Jose A Campillo; Rosa M Moya; Aurelio Luna; Eduardo Osuna; Alfredo Minguela; Francisco Sanchez-Bueno; Maria Rocio Alvarez; Manuel Muro
Journal:  Arch Med Sci       Date:  2019-06-18       Impact factor: 3.318

3.  Moderate hyperkalemia in hospitalized patients with cirrhotic ascites indicates a poor prognosis.

Authors:  Sven Wallerstedt; Magnus Simrén; Staffan Wahlin; Lars Lööf; Rolf Hultcrantz; Klas Sjöberg; Hanna Sandberg Gertzén; Hanne Prytz; Sven Almer; Anders Odén
Journal:  Scand J Gastroenterol       Date:  2013-01-08       Impact factor: 2.423

4.  Alkaline phosphatase: the next independent predictor of the poor 90-day outcome in alcoholic hepatitis.

Authors:  Beata Kasztelan-Szczerbinska; Maria Slomka; Krzysztof Celinski; Mariusz Szczerbinski
Journal:  Biomed Res Int       Date:  2013-09-17       Impact factor: 3.411

Review 5.  The evolution in the prioritization for liver transplantation.

Authors:  Evangelos Cholongitas; Andrew K Burroughs
Journal:  Ann Gastroenterol       Date:  2012

6.  Magnitude of peripheral neuropathy in cirrhosis of liver patients from central rural India.

Authors:  Jyoti Jain; Ramji Singh; Shashank Banait; Nitin Verma; Satish Waghmare
Journal:  Ann Indian Acad Neurol       Date:  2014-10       Impact factor: 1.383

7.  HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus.

Authors:  Lingling He; Shuan Zhang; Xiaoli Liu; Yuyong Jiang; Xianbo Wang; Zhiyun Yang
Journal:  J Diabetes Res       Date:  2017-01-05       Impact factor: 4.011

8.  The heart matters when the liver shatters! Cirrhotic cardiomyopathy: frequency, comparison, and correlation with severity of disease.

Authors:  Iftikhar Haider Naqvi; Khalid Mahmood; Muhammad Naeem; Aneel Sham Vashwani; Syed Ziaullah
Journal:  Prz Gastroenterol       Date:  2016-02-16

9.  Systemic inflammatory response syndrome and model for end-stage liver disease score accurately predict the in-hospital mortality of black African patients with decompensated cirrhosis at initial hospitalization: a retrospective cohort study.

Authors:  Alassan Kouamé Mahassadi; Justine Laure Konang Nguieguia; Henriette Ya Kissi; Anthony Afum-Adjei Awuah; Aboubacar Demba Bangoura; Stanislas Adjeka Doffou; Alain Koffi Attia
Journal:  Clin Exp Gastroenterol       Date:  2018-04-09

Review 10.  Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Ying Peng; Xingshun Qi; Xiaozhong Guo
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.